Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
IQVIA Holdings Inc., commonly known as IQVIA, is a leading provider of research and development services within the healthcare and life sciences sectors. Headquartered in the United States, the company operates globally, with a significant presence across North America, Europe, and Asia. Founded in 2016 through the merger of IMS Health and Quintiles, IQVIA has established itself as a key player in clinical research, data analytics, and technology solutions.
Specialising in innovative R&D services, IQVIA leverages vast healthcare data and advanced analytics to support pharmaceutical, biotech, and medical device companies. Its unique combination of data-driven insights and comprehensive service offerings has earned it a notable market position, enabling clients to accelerate drug development and improve patient outcomes. As a pioneer in the industry, IQVIA continues to shape the future of healthcare research and development.
+46 vs industry average
Iqvia’s score of 79 is higher than 85% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Research Services has below-average carbon intensity
The Research Services industry has reduced its overall emissions by 19% since 2018
Scope 3 accounts for ••• of total emissions.
IQVIA, a US-based research and development services company, reported total carbon emissions of approximately 472.44 million kg CO2e in 2024. This figure includes Scope 1 emissions of around 10.30 million kg CO2e, Scope 2 market-based emissions of approximately 27.04 million kg CO2e, and Scope 3 emissions of about 435.10 million kg CO2e.
Looking back, IQVIA's emissions have fluctuated. In 2023, total emissions were roughly 526.20 million kg CO2e, with Scope 1 at about 8.22 million kg CO2e, Scope 2 market-based at approximately 28.71 million kg CO2e, and Scope 3 at around 489.26 million kg CO2e. The company reported total emissions of around 464.57 million kg CO2e in 2022, with Scope 1 at about 9.90 million kg CO2e, Scope 2 market-based at roughly 31.00 million kg CO2e, and Scope 3 at approximately 423.67 million kg CO2e.
IQVIA has set ambitious climate commitments, with its Science-Based Targets initiative (SBTi) verified targets reflecting a 1.5°C trajectory. The company commits to reaching net-zero greenhouse gas emissions across its value chain by 2050.
Near-term targets include:
For the long term, IQVIA aims for a 90% absolute reduction in Scope 1, 2, and 3 GHG emissions by 2050 from a 2019 base year.
2030
55.1% reduction in Scope 2
IQVIA commits to reduce absolute scope 2 GHG emissions 55.1% by 2030 from a 2019 base year.
2030
55.1% reduction in Scope 1
IQVIA commits to reduce absolute scope 1 GHG emissions 55.1% by 2030 from a 2019 base year.
2050
IQVIA commits to reach net-zero greenhouse gas emissions acr…
IQVIA commits to reach net-zero greenhouse gas emissions across the value chain by 2050.
See all 4 climate goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Common questions about Iqvia’s sustainability data and climate commitments
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more